header-14
Grants

Discovery of new therapeutic targets for aggressive prostate cancer

This project aims to discover new therapeutic targets for a particularly aggressive and therapy resistant form of prostate cancer known as Neuroendocrine prostate cancer (NEPC). Current clinical therapies are not effective at inhibiting the growth and spread of NEPC and men diagnosed with NEPC have a very poor prognosis. It is hoped that findings from our study will reveal new therapeutic strategies to specifically kill this form of prostate cancer and improve outcomes for men with NEPC.

Investigators

Brett Hollier APCRC-Q, IHBI, QUT, TRI
Brian Gabrielli Mater Research Institute, UQ, TRI
Ian Vela APCRC-Q, IHBI, QUT, TRI, PAH

Duration

2018 - 2018

Funding

 

Prostate Cancer Foundation of Australia $100 000

Upcoming Events

Jul 19, 2020 - Jul 21, 2020 ANZUP 2020 Annual Scientific Meeting
Adelaide Convention Centre, South Australia
Aug 18, 2020 - Aug 21, 2020 PA Hospital Health Symposium
Russell Strong Auditorium, Princess Alexandra Hospital, 199 Ipswich Rd, Woolloongabba
Aug 21, 2020 - Aug 23, 2020 21st Asia-Pacific Prostate Cancer Conference
Melbourne Convention and Exhibition Centre, Victoria
Sep 29, 2020 - Oct 02, 2020 ComBio 2020
Melbourne Convention and Exhibition Centre, Victoria
Nov 11, 2020 - Nov 13, 2020 COSA Annual Scientific Meeting
Brisbane Convention and Exhibition Centre, Queensland